Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Did the “Good cholesterol” get even better?

Human Papillomavirus: Toxic Agent to Drive Cervical Cancer

CRISPR-Cas9 for disease resistance in salmon

Did the “Good cholesterol” get even better?
  • BiotechToday
  • World

Did the “Good cholesterol” get even better?

bioxone July 24, 2021July 24, 2021

Avani Dave, Jai Hind College

The good cholesterol has stood up to the prefix given to it as researchers claim it’s added advantages. In addition to the existing features of good cholesterol, it is now known to be associated with improved liver health. HDL is traditionally known for absorbing cholesterol and delivering it to the liver, assisting in reducing the excess cholesterol from accumulating in the arteries. On receiving the cholesterol, the liver eliminates it from the body, preventing an excess build-up. 

The recent study

A recent study by researchers at Washington University School of Medicine, St. Louis was published in the Journal Science. This study conducted on mice indicated that a particular type of high-density lipoprotein (HDL), denoted as HDL3 whose role was not known initially but is recently registered to help in protecting the liver from potential injury. The HDL3 produced in the intestine demonstrated its novel role in protecting the liver by blocking several inflammatory signals (lipopolysaccharide molecules) produced by common gut bacteria. In the absence of HDL3, the signals originating from the intestine reach the liver via the portal vein and bring about the activation of immune cells which causes an unnecessary inflammatory response. Such recurrent immune responses ultimately lead to liver damage like fatty liver disease and liver fibrosis. 

Relationship between intestinal surgery and liver disease

According to Randolph (Author of the study) literature mildly indicated that HDL might interact in the detection of lipopolysaccharides by immune cells and that the presence of lipopolysaccharide receptors could be linked to liver disease. During the research, they utilized a tool from their lab that could track the path followed by HDL from different organs. This helped them to visualize the movement of HDL3 through the portal vein directly to the liver. While in the portal vein, HDL3 was seen to bind to a lipopolysaccharide-binding protein (LBP), this complex further binds to the harmful lipopolysaccharide preventing it from activating immune cells i.e., Kupffer cells thereby averting a potential inflammatory response. Yong-Hyun Han (first author & faculty of Kangwon National University, South Korea) said that, in the absence of HDL3, the LBP can not efficiently block the lipopolysaccharides from triggering an immune response. Thus, explaining why intestinal surgery leads to an aggravated chance of procuring a liver disease. The lesser the HDL3, the more the risk of developing a liver illness.

The conclusion

This study showed the presence of the same protective molecular complexes in human blood samples, pointing towards an identical mechanism. A specific drug was utilized to increase the amount of HDL3 in the mice, which showed positive results. This opens a new arena of prevention and treatment of liver disease, irrespective of the underlying cause being damage to the intestine by high-fat diets, alcohol overuse, or some physical injury. While the research continues for a more detailed comprehension, we hope this opens new doors of improved liver health in the future.

Also read : The role of pre-capture multiplexing in exome sequencing

Source: “Good cholesterol” protects the liver from inflammation and injury, study shows. (2021, July 22). News-Medical.Net. https://www.news-medical.net/news/20210722/Good-cholesterol-protects-the-liver-from-inflammation-and-injury-study-shows.aspx

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

About the Author: Avani Dave is currently in the final year of her bachelor’s degree, majoring in Life Sciences. Holding a good academic and extra-curricular record, she is on a constant journey of acquiring exposure in her field of interest while simultaneously not limiting herself to just that. Avani likes studying Diseases and Syndromes and everything under this umbrella! That being said, she is adept at working across departments and promises to deliver.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged cardiovascular disease diseases fats Good vs Bad cholesterol HDL health inflammation LDL liver liver fibrosis proteins

One thought on “Did the “Good cholesterol” get even better?”

  1. Pingback: Indulgence of dominant primates in vocal communication! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

CRISPR-Cas9 for disease resistance in salmon

BioTech Today July 24, 2021

Kanikah Mehndiratta, MSc, University of Glasgow CRISPR-Cas9 technology is recently being extensively applied in human diseases research in study and effective treatment. Along with its huge therapeutic potential, the technique is also being explored in various other areas where gene editing could improve breeds and promote desirable traits. Traditional approaches to selective breeding in the […]

salmon

Related Post

  • BiotechToday
  • World

Fetus in Fetu analysis by modern Multimode Ultrasound

bioxone October 22, 2020October 21, 2020

Souradip Mallick, National Institute of Technology, Rourkela Fetus in fetu (FIF) has been defined as the presence of one of the twins in the body of the other. It is a condition in which malformed and parasitic fetus is located in the body of the normal fetus. It is very difficult for the radiologist to […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

GATA6+ macrophages: not just phagocytes but also wound healers!!!

bioxone March 15, 2021March 15, 2021

Camelia Bhattacharyya, Amity University Kolkata Knowledge is a huge thing wrapped up in a single word. As the world is changing on a daily basis, so is the knowledge about a topic. There are still several questions to be answered and that’s exactly what brings scientists and researchers in the framework to search for unanswered […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Cancer can be smart, but the immune system is smarter!

bioxone June 11, 2021June 11, 2021

Ananya Dutta, Bose Institute This is the aphorism of Memorial Sloan Kettering (MSK) Cancer Center, New York, USA.  At MSK it is believed that immunotherapy is one of the most promising treatments to treat, cure, and eventually prevent cancer. Immunotherapy cradled from MSK about more than a century ago. William Coley (1893), a surgeon at […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy